August 2008

Editorial

Invest in Partnering - a Key to Success

Medicon Valley's market for innovation is being challenged by a classic catch-22 situation caused by an uncontrollable level of success and unfortunate timing. Many of the region's innovative companies have successfully matured towards an exit, while the general economic situation has jammed the exit market, resulting in the companies requesting additional capital to stay in market. Thus, investors are expecting late stage development results, while innovators wait for additional capital to continue development. Read more

 

 

 

MVA Project News

Meeting Medicon Valley 2008: Conference on 24 September

Join MVA's inspiring conference in Bella Center on 24 September about future partnering strategies. The conference programme has now been finalised and features international industry experts and academic speakers as well as a poster session exhibiting the region's biotech industry. The event will provide an update on Medicon Valley's biotech industry, future investment opportunities, industry collaborations and business partnerships. Read more

 

News from Medicon Valley

Clinical Trials Update

Read the latest update on clinical trials performed by MVA members here.

People on the Move

Read the latest news about people in Medicon Valley here.

Call for Applications to the Danish Elite Research Prize and the Elite Research Scholarship

The Danish Ministry of Science, Technology and Innovation this year offers five Elite Research Prizes of one million DDK to outstanding researchers for an excellent contribution to Danish science and 16 Elite Research Scholarships of 250,000 DKK to very talented PhD students enrolled in Danish Research Institutions to conduct research. Read more

 

Bavarian Nordic Announces Partnership with NCI in the US

Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute in the US, thereby obtaining intellectual property rights covering a prostate cancer vaccine candidate in late phase II clinical development. Read more

University of Copenhagen still No 8 in Europe

The University of Copenhagen ranks 45 worldwide and 8 in Europe on the Academic Ranking of World Universities published by Shanghai Jiao Tong University. Read more

New Members to Danish Research Councils

The Danish Minister of Science, Helge Sander, has appointed ten new members to the Danish Independent Research Council and the Danish Strategic Research Council. Read more  

Probi's Dietary Supplements to be Launched on Eight New European Markets

Probi continues to expand its dietary supplement business and has now signed a distribution agreement with Proton System, a Serbian pharmaceutical company. Read more

Cyncron and BaseCon Form Strategic Partnership in Drug Safety IT Solutions

Cyncron and BaseCon have agreed on a strategic partnership. Together, Cyncron and BaseCon will offer drug safety solutions to biotech companies in Medicon Valley. Read more

ACADIA Pharmaceuticals Secures Committed Equity Financing Facility

ACADIA Pharmaceuticals has announced that it has entered into a Committed Equity Financing Facility with Kingsbridge Capital. Read more

Estonia Fourth Country to Sign Up for ESS in Lund

Estonia has become the fourth country to formally support the building of the ESS in Lund. A total of nine countries stand behind ESS Scandinavia. Read more

Sunstone Capital Raises more than EUR 180 Million for Investments in Life Science

Sunstone Capital has announced the second closing of its fundraising that began in 2007. New investors include institutional investors Sampension Private Equity and Finnish Industry Investment. Read more

 

For more news about Medicon Valley, visit the MVA News section.

 

 

 

Media News

European Life Science Journal - Summer Edition 2008

Read the latest edition of the European Life Science Journal.

New Members

Beaufort Advisors, LLC

Beaufort Advisors is a CRO providing customized solutions to Pharmaceutical, Medical Device, IVD and Molecular Diagnostics companies world wide. Our professional services include Regulatory Consulting, Clinical Trial Management, and Quality Management. Beaufort Advisors combines clinical research and regulatory compliance expertise with exceptional client service to deliver consistent, reliable, and high-value results for our clients.

Contact: sky@beaufortadvisors.com - www.beaufortadvisors.com - +1 757 383 6000

GEA Pharmaceutical A/S

GEA Pharmaceutical A/S provides integrated development services covering drug product (finished dosage forms), drug substance (API) development to API production, including regulatory documentation, procedures, strategies, and patent landscape investigations. GEA Pharmaceutical is a CRO and a CMO all on one site, serving its clients through the global sales organization of its parent, Pharmazell. With 330 staff, Pharmazell operates cGMP sites in Copenhagen/Denmark, Raubling/Germany, Chennai/India, and Vizag/India. GEA Pharmaceutical develops and manufactures pharmaceuticals since 1927.

Contact: www.gea-pharma.com - +45 36 79 45 00

  

  

Interlace-Invent ApS

Interlace-Invent ApS is a research-based consultancy, operating from five European countries and specialising in the development and management of competitive innovation environments incl. Living Labs and business incubators. Clients include hospitals and other providers of healthcare. Interlace-Invent helps design and lead projects with strong stakeholder and end-user involvement already in the first phases of the innovation process. Innovation in the health services, procurement systems for medical devices, mobilization of investment capital, and management of biotech cluster development are listed as special services.

Contact: www.interlace-invent.com - +45 30 71 17 61

SEED Capital Denmark

SEED Capital Denmark is one of the largest Danish operators within early life science venture with 200 million USD under management. Currently the life science portfolio comprises 30 companies. SEED Capital Denmark has close links to leading research institutions in Medicon Valley. The fund can invest at the pre-seed stage of a start-up company and has the ability to follow suit through later financing rounds all the way to exit. The geographical focus is Denmark and South Sweden. SEED Capital Denmark has attracted more than 300 million USD in external funding to its portfolio over the last 3 years.

Contact: info@seedcapital.dk - www.seedcapital.dk - +45 45 25 61 55

Skanska Øresund

Skanska Øresund is a property developer within commercial properties. Our mission is to develop, let and sell the best property projects in office buildings, logistics and retail, mainly in the Øresund region.

Contact: info@skanska.dk - www.skanska.com - +45 44 68 05 65

 

See the full list of MVA members here.

 

The MVA Newsletter is a monthly newsletter service, which provides you with news on MVA projects, members and the Medicon Valley region. As a MVA member, please feel free to send us your press releases. When possible, we will run your news in the MVA Newsletter or in our website